U.S. markets open in 8 hours 31 minutes
  • S&P Futures

    4,271.75
    -9.25 (-0.22%)
     
  • Dow Futures

    33,650.00
    -68.00 (-0.20%)
     
  • Nasdaq Futures

    13,544.50
    -33.25 (-0.24%)
     
  • Russell 2000 Futures

    2,011.50
    -5.40 (-0.27%)
     
  • Crude Oil

    91.18
    -0.91 (-0.99%)
     
  • Gold

    1,809.30
    -6.20 (-0.34%)
     
  • Silver

    20.61
    -0.08 (-0.40%)
     
  • EUR/USD

    1.0253
    -0.0004 (-0.04%)
     
  • 10-Yr Bond

    2.8490
    0.0000 (0.00%)
     
  • Vix

    19.53
    -0.67 (-3.32%)
     
  • GBP/USD

    1.2117
    -0.0022 (-0.18%)
     
  • USD/JPY

    133.1990
    -0.2810 (-0.21%)
     
  • BTC-USD

    24,837.23
    +274.60 (+1.12%)
     
  • CMC Crypto 200

    592.06
    +20.78 (+3.64%)
     
  • FTSE 100

    7,500.89
    +34.98 (+0.47%)
     
  • Nikkei 225

    28,891.25
    +344.27 (+1.21%)
     

BioLife Solutions to Report Second Quarter 2022 Financial Results and Provide Business Update on August 9, 2022

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

BOTHELL, Wash., Aug. 2, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's second quarter 2022 financial results will be released after market close on Tuesday, August 9th. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day.  Management will provide an overview of the Company's financial results and a general business update.

BioLife Solutions New Logo 2021 (PRNewsfoto/BioLife Solutions, Inc.)
BioLife Solutions New Logo 2021 (PRNewsfoto/BioLife Solutions, Inc.)

To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at https://www.biolifesolutions.com/earnings. In addition, the conference call will be accessible by dialing toll-free (800) 715-9871 for domestic callers and (646) 307-1963 for international callers. The conference ID number is 2389359. A webcast replay will be available approximately two hours after the call and will be archived on https://www.biolifesolutions.com/ for 90 days.

About BioLife Solutions

BioLife Solutions is a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets. Our tools portfolio includes our proprietary CryoStor® and HypoThermosol® biopreservation media for shipping and storage, the ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system,  high capacity cryogenic storage freezersStirling Ultracold mechanical freezers, SciSafe biologic storage services, and Sexton Biotechnologies cell processing tools.  For more information, please visit www.biolifesolutions.com, www.scisafe.com, www.stirlingultracold.com, or www.sextonbio.com and follow BioLife on Twitter.

Contact Information:

At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com

Investors
LHA Investor Relations
Jody Cain
(310) 691-7100
jcain@lhai.com

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-report-second-quarter-2022-financial-results-and-provide-business-update-on-august-9-2022-301598254.html

SOURCE BioLife Solutions, Inc.